{"id":1068011,"date":"2021-02-06T08:51:02","date_gmt":"2021-02-06T13:51:02","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/crispr-therapeutics-to-participate-in-the-guggenheim-healthcare-talks-2021-oncology-day\/"},"modified":"2024-08-18T11:41:55","modified_gmt":"2024-08-18T15:41:55","slug":"crispr-therapeutics-to-participate-in-the-guggenheim-healthcare-talks-2021-oncology-day","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/crispr-therapeutics-to-participate-in-the-guggenheim-healthcare-talks-2021-oncology-day.php","title":{"rendered":"CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day"},"content":{"rendered":"<p><![CDATA[ZUG, Switzerland and CAMBRIDGE, Mass., Feb.  05, 2021  (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the Guggenheim Healthcare Talks 2021 Oncology Day on Friday, February 12, 2021, at 3:30 p.m. ET.]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2021\/02\/05\/2170666\/0\/en\/CRISPR-Therapeutics-to-Participate-in-the-Guggenheim-Healthcare-Talks-2021-Oncology-Day.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day\">CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology Day <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/crispr-therapeutics-to-participate-in-the-guggenheim-healthcare-talks-2021-oncology-day.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068011","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068011"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068011"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068011\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}